サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1785861

スポーツ医学のための血液ベースのバイオマーカーの世界市場

Blood-based Biomarker for Sports Medicine

出版日
ページ情報
英文 191 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
スポーツ医学のための血液ベースのバイオマーカーの世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スポーツ医学のための血液ベースのバイオマーカーの世界市場は2030年までに9億4,490万米ドルに達する見込み

2024年に6億9,010万米ドルと推定されるスポーツ医学のための血液ベースのバイオマーカーの世界市場は、2030年には9億4,490万米ドルに達し、分析期間2024-2030年のCAGRは5.4%で成長すると予測されます。本レポートで分析したセグメントの1つであるクレアチンキナーゼ検査は、CAGR 5.2%を記録し、分析期間終了時には1億9,200万米ドルに達すると予測されます。ミオグロビン検査セグメントの成長率は、分析期間中CAGR 4.9%と推定されます。

米国市場は推定1億8,800万米ドル、中国はCAGR8.4％で成長予測

米国のスポーツ医学のための血液ベースのバイオマーカー市場は、2024年に1億8,800万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.4%で推移し、2030年には1億8,810万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.3%と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

スポーツ医学向け血液ベースバイオマーカーの世界市場- 主要動向と促進要因のまとめ

なぜ血液ベースのバイオマーカーがスポーツ医学に革命を起こすのか？

血液ベースのバイオマーカーは、アスリートの生理学的状態、傷害リスク、回復の進捗状況、全体的なパフォーマンスの最適化に関するリアルタイムの洞察を提供することで、スポーツ医学を変革しています。タンパク質、酵素、ホルモン、代謝物を含むこれらのバイオマーカーは、筋損傷、炎症、水分補給レベル、代謝ストレスをモニターする非侵襲的な方法を提供します。スポーツ科学の進歩に伴い、コーチ、スポーツ医、リハビリテーション専門家は、トレーニングレジメンを個別化し、怪我を予防し、回復を早めるために、血液ベースのバイオマーカー検査を活用するようになってきています。

スポーツにおける精密医療への需要の高まりは、バイオマーカー研究の進歩と相まって、プロのアスリート、フィットネス愛好家、リハビリテーション・センターの間で血液検査の採用に拍車をかけています。血液ベースのバイオマーカーは現在、酸化ストレス、乳酸閾値、栄養欠乏の評価に使用されており、エビデンスに基づくパフォーマンス向上戦略を可能にしています。さらに、スポーツチームや医療機関は、バイオマーカー分析をウェアラブル技術やAI主導の分析と統合することで、継続的な健康モニタリングや疲労に関連する傷害の早期発見を実現しています。アスリートのウェルビーイングと長寿への注目が高まる中、血液ベースのバイオマーカーはスポーツ医学の基本的なツールになると考えられています。

技術の進歩は、スポーツ医学における血液ベースのバイオマーカー検査をどのように強化しているのか？

バイオマーカー検出、マイクロ流体工学、AI主導型診断における最先端の技術革新により、血液ベースのバイオマーカー検査は、スポーツ医学への応用において、よりアクセスしやすく、正確で、効率的なものとなっています。この分野における最も重要な進歩の一つは、最小限の血液サンプルで迅速なバイオマーカー分析を可能にするポイントオブケア（POC）およびラボオンチップ技術の開発です。これらのポータブル診断デバイスにより、アスリートや医療専門家は、従来のラボベースの検査を必要とせずにリアルタイムのパフォーマンス・モニタリングを行うことができ、利便性と効率性が向上します。

もうひとつの重要なイノベーションは、バイオマーカーデータ解析におけるAIと機械学習（ML）の統合です。AIを搭載したアルゴリズムは、バイオマーカーの経時的変動を分析し、オーバートレーニング、傷害リスク、最適な回復ウィンドウに関連するパターンを特定することができます。さらに、プロテオミクス、メタボロミクス、トランスクリプトミクスなどのオミクス技術の台頭は、測定可能なバイオマーカーの範囲を拡大し、筋再生、免疫機能、代謝効率に関するより深い洞察を提供しています。また、特定のスポーツやアスリートのプロファイルに合わせたパーソナライズドバイオマーカーパネルも登場し、カスタマイズされたトレーニングや傷害予防戦略を可能にしています。技術が進化し続ける中、血液ベースのバイオマーカー検査は、健康リスクを最小限に抑えながら競技パフォーマンスを最大化するための不可欠なツールになりつつあります。

どのような市場動向がスポーツ医学用血液ベースバイオマーカー産業の成長を牽引しているか？

データ駆動型のトレーニングとパフォーマンスの最適化が重視されるようになったことは、スポーツ医学における血液ベースのバイオマーカー市場を形成する最も影響力のある動向の1つです。スポーツアナリティクスの台頭により、エリートアスリートやチームは競争力を得るためにトレーニングプログラムにバイオマーカーモニタリングを組み込んでいます。この動向は、サイクリング、ランニング、トライアスロンなどの持久系スポーツで特に顕著であり、リアルタイムバイオマーカー分析により、アスリートは最高のパフォーマンスを発揮するために水分補給、栄養補給、回復プロトコルを調整することができます。

市場成長を促進するもう一つの主要動向は、傷害予防とリハビリテーション・アプリケーションの拡大です。スポーツ医学の専門家は、血液ベースのバイオマーカーを活用して筋肉疲労、炎症、組織損傷の初期兆候を特定し、怪我が発生する前に予防的な介入を可能にしています。さらに、長寿に焦点を当てたフィットネス・プログラムの人気が高まっていることから、アマチュア・アスリートやフィットネス愛好家の間でバイオマーカーに基づくウェルネス評価の需要が高まっています。消費者直販（DTC）のバイオマーカー検査サービスの台頭も市場拡大に拍車をかけており、各社は個人の生理学に基づいてフィットネス、栄養、回復戦略を導く個別化バイオマーカーレポートを提供しています。

スポーツ医学における血液ベースのバイオマーカーの将来を形作る主な成長要因は何か？

スポーツ医学における血液ベースのバイオマーカー市場の成長は、精密医療の採用の増加、バイオマーカー技術の進歩、データ駆動型のスポーツパフォーマンス管理に対する認識の高まりなど、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、スポーツ関連傷害の発生率の上昇と早期発見戦略の必要性です。バイオマーカー検査によって、アスリートは筋損傷、酸化ストレス、炎症マーカーを追跡できるようになり、早期介入と回復時間の短縮が可能になります。

市場を形成するもう一つの重要な促進要因は、個別化された健康とフィットネス・ソリューションに対する需要の高まりです。ウェアラブル技術とモバイルヘルスプラットフォームの拡大に伴い、アスリートやフィットネス愛好家は、トレーニングと回復を最適化するためにリアルタイムのバイオマーカーによる洞察を求めています。さらに、スポーツ科学機関、バイオテクノロジー企業、競技団体間の連携により、新たなパフォーマンスや怪我に関連するバイオマーカーの調査が加速しています。AIを活用した分析、非侵襲的な検査方法、モバイルバイオマーカーモニタリングが進化し続ける中、スポーツ医学における血液ベースのバイオマーカー検査の将来は、これまでにない方法で競技パフォーマンスを向上させ、傷害リスクを軽減し、アスリートの健康全般をサポートすることを約束します。

セグメント

検査タイプ（クレアチンキナーゼ検査、ミオグロビン検査、乳酸検査、WBC検査、尿素検査、C反応性タンパク質検査、脂質およびタンパク質ヒドロペルオキシド検査、IL-6検査、その他の検査タイプ）

調査対象企業の例

  • Abbott Laboratories, Inc.
  • ARUP Laboratories
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • C2N Diagnostics LLC
  • Cleveland Diagnostics
  • Diadem srl.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Minomic International Limited
  • ProteoMediX
  • Raybiotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29651

Global Blood-based Biomarker for Sports Medicine Market to Reach US$944.9 Million by 2030

The global market for Blood-based Biomarker for Sports Medicine estimated at US$690.1 Million in the year 2024, is expected to reach US$944.9 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Creatine Kinase Testing, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$192.0 Million by the end of the analysis period. Growth in the Myoglobin Testing segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$188.0 Million While China is Forecast to Grow at 8.4% CAGR

The Blood-based Biomarker for Sports Medicine market in the U.S. is estimated at US$188.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$188.1 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Blood-Based Biomarker Market for Sports Medicine - Key Trends & Drivers Summarized

Why Are Blood-Based Biomarkers Revolutionizing Sports Medicine?

Blood-based biomarkers are transforming sports medicine by providing real-time insights into an athlete’s physiological condition, injury risks, recovery progress, and overall performance optimization. These biomarkers, which include proteins, enzymes, hormones, and metabolites, offer a non-invasive way to monitor muscle damage, inflammation, hydration levels, and metabolic stress. As sports science advances, coaches, sports physicians, and rehabilitation specialists are increasingly utilizing blood-based biomarker testing to personalize training regimens, prevent injuries, and accelerate recovery times.

The growing demand for precision medicine in sports, coupled with advancements in biomarker research, has fueled the adoption of blood testing among professional athletes, fitness enthusiasts, and rehabilitation centers. Blood-based biomarkers are now being used to assess oxidative stress, lactate thresholds, and nutritional deficiencies, allowing for evidence-based performance enhancement strategies. Additionally, sports teams and medical institutions are integrating biomarker analysis with wearable technology and AI-driven analytics to provide continuous health monitoring and early detection of fatigue-related injuries. With the increasing focus on athlete well-being and longevity, blood-based biomarkers are set to become a fundamental tool in sports medicine.

How Are Technological Advancements Enhancing Blood-Based Biomarker Testing in Sports Medicine?

Cutting-edge innovations in biomarker detection, microfluidics, and AI-driven diagnostics are making blood-based biomarker testing more accessible, accurate, and efficient for sports medicine applications. One of the most significant advancements in this field is the development of point-of-care (POC) and lab-on-a-chip technologies, which enable rapid biomarker analysis with minimal blood samples. These portable diagnostic devices allow athletes and medical professionals to conduct real-time performance monitoring without requiring traditional lab-based testing, enhancing convenience and efficiency.

Another key innovation is the integration of AI and machine learning (ML) in biomarker data analysis. AI-powered algorithms can analyze biomarker fluctuations over time, identifying patterns associated with overtraining, injury risk, and optimal recovery windows. Additionally, the rise of omics technologies-such as proteomics, metabolomics, and transcriptomics-is expanding the range of measurable biomarkers, providing deeper insights into muscle regeneration, immune function, and metabolic efficiency. Personalized biomarker panels tailored to specific sports and athlete profiles are also emerging, enabling customized training and injury prevention strategies. As technology continues to evolve, blood-based biomarker testing is becoming an indispensable tool for maximizing athletic performance while minimizing health risks.

Which Market Trends Are Driving Growth in the Blood-Based Biomarker Industry for Sports Medicine?

The increasing emphasis on data-driven training and performance optimization is one of the most influential trends shaping the market for blood-based biomarkers in sports medicine. With the rise of sports analytics, elite athletes and teams are integrating biomarker monitoring into their training programs to gain a competitive edge. This trend is particularly evident in endurance sports, such as cycling, running, and triathlons, where real-time biomarker analysis helps athletes adjust hydration, nutrition, and recovery protocols for peak performance.

Another key trend driving market growth is the expansion of injury prevention and rehabilitation applications. Sports medicine professionals are leveraging blood-based biomarkers to identify early signs of muscle fatigue, inflammation, and tissue damage, enabling proactive interventions before injuries occur. Additionally, the increasing popularity of longevity-focused fitness programs has driven demand for biomarker-based wellness assessments among amateur athletes and fitness enthusiasts. The rise of direct-to-consumer (DTC) biomarker testing services is also fueling market expansion, with companies offering personalized biomarker reports that guide fitness, nutrition, and recovery strategies based on individual physiology.

What Are the Key Growth Drivers Shaping the Future of Blood-Based Biomarkers in Sports Medicine?

The growth in the blood-based biomarker market for sports medicine is driven by several key factors, including the increasing adoption of precision medicine, advancements in biomarker technology, and the growing recognition of data-driven sports performance management. One of the primary growth drivers is the rising incidence of sports-related injuries and the need for early detection strategies. Biomarker testing enables athletes to track muscle damage, oxidative stress, and inflammatory markers, allowing for early intervention and reduced recovery times.

Another crucial driver shaping the market is the growing demand for personalized health and fitness solutions. With the expansion of wearable technology and mobile health platforms, athletes and fitness enthusiasts are seeking real-time biomarker insights to optimize training and recovery. Additionally, collaborations between sports science institutions, biotech companies, and athletic organizations are accelerating research into new performance and injury-related biomarkers. As AI-powered analytics, non-invasive testing methods, and mobile biomarker monitoring continue to evolve, the future of blood-based biomarker testing in sports medicine promises to enhance athletic performance, reduce injury risks, and support overall athlete health in unprecedented ways.

SCOPE OF STUDY:

The report analyzes the Blood-based Biomarker for Sports Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Testing Type (Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid and Protein Hydroperoxides Testing, IL-6 Testing, Other Testing Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories, Inc.
  • ARUP Laboratories
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • C2N Diagnostics LLC
  • Cleveland Diagnostics
  • Diadem srl.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Minomic International Limited
  • ProteoMediX
  • Raybiotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Blood-based Biomarker for Sports Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Performance Optimization Throws the Spotlight on Blood-Based Biomarkers as Precision Tools in Sports Medicine
    • Growing Emphasis on Injury Prevention and Recovery Propels Growth in Biomarker-Based Monitoring Protocols
    • Shift Toward Evidence-Based Training Models Expands the Addressable Market for Diagnostic Biomarkers in Athletes
    • Integration of Biomarker Testing in Personalized Fitness Plans Strengthens the Business Case for Sports-Specific Diagnostics
    • Technological Advancements in Biomarker Detection Platforms Drive Adoption in Real-Time Athlete Monitoring
    • Increasing Application of Inflammatory and Muscle Damage Biomarkers Spurs Demand in Rehabilitation Programs
    • Booming Professional Sports and Elite Athlete Ecosystem Accelerates Demand for Performance Tracking via Blood Testing
    • Adoption of Metabolic and Hormonal Biomarkers Drives Deeper Insights into Athletic Fatigue and Overtraining
    • Wider Use of Nutritional Biomarkers Generates Opportunities in Sports Nutrition Optimization and Supplementation Strategies
    • Integration with Wearable Tech and Data Analytics Strengthens Demand for Dynamic, Continuous Monitoring Solutions
    • Emerging Role of Genomic and Epigenetic Biomarkers Expands the Frontiers of Predictive Sports Medicine
    • Rising Interest in Biomarkers for Mental Stress and Recovery Propels Growth in Holistic Athlete Health Management
    • Demand from Amateur and Recreational Athletes Fuels Market Expansion Beyond Elite Sports Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood-based Biomarker for Sports Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood-based Biomarker for Sports Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Creatine Kinase Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Creatine Kinase Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Creatine Kinase Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Myoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Myoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Myoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Lactate Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Lactate Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Lactate Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for WBC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for WBC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for WBC Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urea Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urea Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Urea Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for C-reactive Protein Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for C-reactive Protein Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for C-reactive Protein Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Lipid & Protein Hydroperoxides Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Lipid & Protein Hydroperoxides Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Lipid & Protein Hydroperoxides Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for IL-6 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for IL-6 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for IL-6 Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Testing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • CHINA
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood-based Biomarker for Sports Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Blood-based Biomarker for Sports Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • INDIA
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Blood-based Biomarker for Sports Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Blood-based Biomarker for Sports Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood-based Biomarker for Sports Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Blood-based Biomarker for Sports Medicine by Testing Type - Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Blood-based Biomarker for Sports Medicine by Testing Type - Percentage Breakdown of Value Sales for Creatine Kinase Testing, Myoglobin Testing, Lactate Testing, WBC Testing, Urea Testing, C-reactive Protein Testing, Lipid & Protein Hydroperoxides Testing, IL-6 Testing and Other Testing Types for the Years 2015, 2025 & 2030

IV. COMPETITION